2213 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1
Kung, Che-Pei, Bross, Emily A., Kuzmicki, Catherine E., Benjamin, Michael, Maggi, Leonard B., Weber, Jason D.
Published in Journal of clinical and translational science (01.06.2018)
Published in Journal of clinical and translational science (01.06.2018)
Get full text
Journal Article
Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
Kung, Che-Pei, Cottrell, Kyle A., Ryu, Sua, Bramel, Emily R., Kladney, Raleigh D., Bao, Emily A., Freeman, Eric C., Sabloak, Thwisha, Maggi Jr, Leonard, Weber, Jason D.
Published in Oncogene (07.01.2021)
Published in Oncogene (07.01.2021)
Get full text
Journal Article
Abstract P4-08-03: Tumor suppressors p53 and ARF control ADAR1-driven tumorigenicity in triple negative breast cancer
Kung, Che-Pei, Kuzmicki, Catherine E, Bross, Emily A, Ryu, Sua, Freeman, Eric, Sabloak, Thwisha, Bramel, Emily R, Maggi, Leonard B, Weber, Jason D
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
ADAR1 editing dependency in triple-negative breast cancer
Che-Pei Kung, Cottrell, Kyle A, Ryu, Sua, Bramel, Emily R, Kladney, Raleigh D, Bross, Emily A, Maggi, Leonard, Weber, Jason D
Published in bioRxiv (02.02.2020)
Published in bioRxiv (02.02.2020)
Get full text
Paper